Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chan Lin

Showing results (511-520 of 546) with videos related to

Pageof 55
Sort By:
Molecular Oncology|August 3, 2020
Downregulation of STK4 promotes colon cancer invasion/migration through blocking β-catenin degradationCheng-Han Lin, Tai-I Hsu, Pei-Yu Chiou, et al.
Theranostics|March 23, 2021
Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathySzu-Jung Chen, Li-Hsien Chen, Yu-Min Yeh, et al.
Molecular Carcinogenesis|April 4, 2023
Dual role of sprouty2 as an inhibitor of RAS/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancerChung-Ta Lee, Chien-An Chu, Yu-Ming Wang, et al.
Abdominal Radiology (New York)|February 21, 2018
Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostateMahesh B Nagarajan, Steven S Raman, Pechin Lo, et al.
The Kaohsiung Journal of Medical Sciences|February 9, 2016
Off-treatment efficacy of 3-year nucleos(t)ide analogues in chronic hepatitis B patientsChing-Chung Lin, Ming-Jong Bair, Chih-Jen Chen, et al.
Journal of Atherosclerosis and Thrombosis|November 23, 2022
Real-World Analyses of the Treatment Conditions in Patients Initiating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor in TaiwanPo-Lin Lin, Yen-Wen Wu, Chao-Feng Lin, et al.
Scientific Reports|November 10, 2017
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLATChen-Yuan Lin, Chia-Fong Cho, Shih-Ting Bai, et al.
Antimicrobial Resistance and Infection Control|March 23, 2023
Patient and ward related risk factors in a multi-ward nosocomial outbreak of COVID-19: Outbreak investigation and matched case-control studyJenine Leal, Heidi M O'Grady, Logan Armstrong, et al.
British Journal of Cancer|August 23, 2022
CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancerChi-Che Hsieh, Sen-Huei Hsu, Chih-Yu Lin, et al.
Anticancer Research|December 16, 2014
Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancerMing-Yu Lien, Liang-Chih Liu, Hwei-Chung Wang, et al.
Pageof 55

Showing results (511-520 of 546) with videos related to

Sort By:
Pageof 55
Molecular Oncology|August 3, 2020
Downregulation of STK4 promotes colon cancer invasion/migration through blocking β-catenin degradationCheng-Han Lin, Tai-I Hsu, Pei-Yu Chiou, et al.
Theranostics|March 23, 2021
Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathySzu-Jung Chen, Li-Hsien Chen, Yu-Min Yeh, et al.
Molecular Carcinogenesis|April 4, 2023
Dual role of sprouty2 as an inhibitor of RAS/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancerChung-Ta Lee, Chien-An Chu, Yu-Ming Wang, et al.
Abdominal Radiology (New York)|February 21, 2018
Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostateMahesh B Nagarajan, Steven S Raman, Pechin Lo, et al.
The Kaohsiung Journal of Medical Sciences|February 9, 2016
Off-treatment efficacy of 3-year nucleos(t)ide analogues in chronic hepatitis B patientsChing-Chung Lin, Ming-Jong Bair, Chih-Jen Chen, et al.
Journal of Atherosclerosis and Thrombosis|November 23, 2022
Real-World Analyses of the Treatment Conditions in Patients Initiating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor in TaiwanPo-Lin Lin, Yen-Wen Wu, Chao-Feng Lin, et al.
Scientific Reports|November 10, 2017
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLATChen-Yuan Lin, Chia-Fong Cho, Shih-Ting Bai, et al.
Antimicrobial Resistance and Infection Control|March 23, 2023
Patient and ward related risk factors in a multi-ward nosocomial outbreak of COVID-19: Outbreak investigation and matched case-control studyJenine Leal, Heidi M O'Grady, Logan Armstrong, et al.
British Journal of Cancer|August 23, 2022
CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancerChi-Che Hsieh, Sen-Huei Hsu, Chih-Yu Lin, et al.
Anticancer Research|December 16, 2014
Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancerMing-Yu Lien, Liang-Chih Liu, Hwei-Chung Wang, et al.
Pageof 55